Q&A: What to Know About the Drug-Resistant Fungus, Candida auris

Fungal researcher Christina Cuomo discusses the spread of infections plaguing hospitals across the world.

Written byEmma Yasinski
| 3 min read
christina cuomo candida auris

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A mysterious fungal infection has been cropping up in hospitals across the globe. While the mortality rate is unclear, especially because most patients have significant other health problems, it appears to be fatal in about 30–60 percent of patients. So far this year, the Centers for Disease Control and Prevention (CDC) has documented 587 confirmed cases in the US. Health officials are concerned about the microbe’s resistance to known antifungal treatments and its ability to survive in hospital rooms long after a patient has passed. Multiplying these concerns was the observation reported in The New York Times this month that “hospitals and local governments are reluctant to disclose outbreaks for fear of being seen as infection hubs.”

The fungus is a recently discovered species named Candida auris. The Scientist spoke with Christina Cuomo, a senior group leader of the Fungal Genomics Group at the Broad Institute of MIT and Harvard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • emma yasinski

    Emma is a Florida-based freelance journalist and regular contributor for The Scientist. A graduate of Boston University’s Science and Medical Journalism Master’s Degree program, Emma has been covering microbiology, molecular biology, neuroscience, health, and anything else that makes her wonder since 2016. She studied neuroscience in college, but even before causing a few mishaps and explosions in the chemistry lab, she knew she preferred a career in scientific reporting to one in scientific research.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies